Hera News & Events


Hera Biolabs announces Molecular Cancer Therapeutics publication on immunodeficient rats for oncology research

Hera Biolabs, the University of Michigan, Case Western Reverse University and other collaborators are announcing a recent publication in the American Association for Cancer Research (AACR) journal, Molecular Cancer Therapeutics, entitled, "Sprague Dawley Rag2-null rats created from engineered spermatogonial stem cells are immunodeficient and permissive to human xenografts."

OncoRat® PDX models highlighted in Drug Discovery News (DDN) Special Report on Cancer: Aiming for Avatars

While advances in in-vitro platforms have allowed researchers to better visually monitor a variety of aspects of tumor biology, a significant limitation of 3D cultured models for patient therapeutic monitoring or “patient avatars” is the lack of important components, such as the influence of surrounding tissues and potential cell-to-cell interactions, when studying cancer progression, treatment responses and outcomes. Patient derived xenograft models or PDX models overcome these limitations and other research challenges and provide a platform that is believed to more closely mimic the patient tumor.

Humanized immune-system SRG Rats™ & mice for immuno-oncology

The SRG rat demonstrates robust immune-system humanization with peripheral blood [...]

Hera Presents at SOT 2017 & AACR 2017 Recap

Hera strives to provide its clients with superior preclinical toxicology [...]

Chimeric Humanized Mouse Models: Understanding Human and Mouse Cell Interactions

Humanized liver mouse models are increasingly being used in preclinical [...]

Transposon Mutagenesis Helps Identify Genes Mediating Drug Resistance in the Treatment of CLL

First time treatment of Chronic Lymphocratic Leukemia (CLL) generally requires [...]

PDX Models of Lung Cancer Closely Mimic Characteristics of Patient Primary Tumors

Despite ongoing research, lung cancers have remained among the most [...]

Rat Provides a More Robust & Convenient Animal Infection Model for Hepatitis E Virus

Hepatitis E virus (HEV) is estimated to cause more than 56 thousand deaths each year, and although most infections remain asymptomatic, HEV is still considered one of the most common causes of acute viral hepatitis and is an ongoing concern for immunosuppressed transplant patients.

Hera BioLabs, a KY based contract research lab announces $400K Kentucky SBIR/STTR Matching Funds Grant

Hera BioLabs (“Hera”), a Lexington KY based contract research organization [...]

Hera BioLabs in Genetic Engineering News

Hera BioLabs and our VP of Research and Development Tseten [...]